$2.34
0.094.00%
At close: May 8, 5:00 PM EST
$2.30
-0.0385-1.65%
After Hours: May 8, 7:58 PM EST
Grace Therapeutics Inc Earnings Estimates
GRCENASDAQ
Grace Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:GRCE
Grace Therapeutics (GRCE) is scheduled to report Q4 earnings on June 22, 2026. Analysts estimate EPS of $-0.21 and quarterly revenue of N/A.
In the most recent quarter (Q3), Grace Therapeutics reported EPS of $-0.14, beating estimates of $-0.27 by 0.48%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Grace Therapeutics has beaten EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Grace Therapeutics has averaged an EPS surprise of 0.73% and a revenue surprise of 0.00%.
Earnings Date
Jun 22
EPS Estimate
$-0.210
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Grace Therapeutics Earnings History
Analyze the earnings history of Grace Therapeutics using advanced sorting and filters.
Loading calendar...
Grace Therapeutics (GRCE) Earnings Per Share
The chart below shows Grace Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Grace Therapeutics (GRCE) Revenue
The chart below shows Grace Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Grace Therapeutics (NASDAQ:GRCE) reporting earnings?
Grace Therapeutics (GRCE) is scheduled to report earnings on June 22, 2026. The last reported earnings were for reported on February 12, 2026 for Q3.
What were the latest earnings per share (EPS) for Grace Therapeutics (NASDAQ:GRCE)?
The Actual EPS was $-0.14, which beat the estimate of $-0.27.
What were Grace Therapeutics’s (NASDAQ:GRCE) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
